Challenges in hospice and end-of-life care in the transfusion-dependent patient

Article indépendant

RODENBACH, Rachel | CAPRIO, Thomas | LOH, Kah Poh

Despite promising advances leading to improved survival, many patients with hematologic malignancies end up dying from their underlying disease. Their end-of-life (EOL) care experience is often marked by worsening symptoms, late conversations about patient values, increased healthcare utilization, and infrequent involvement of palliative care and hospice services. There are several challenges to the delivery of high-quality EOL care that span across disease, patient, clinician, and system levels. These barriers include an unpredictable prognosis, the patient's prognostic misunderstandings and preference to focus on the immediate future, and the oncologist's hesitancy to initiate EOL conversations. Additionally, many patients with hematologic malignancies have increasing transfusion requirements at the end of life. The hospice model often does not support ongoing blood transfusions for patients, creating an additional and substantial hurdle to hospice utilization. Ultimately, patients who are transfusion-dependent and elect to enroll in hospice do so often within a limited time frame to benefit from hospice services. Strategies to overcome challenges in EOL care include encouraging repeated patient-clinician conversations that set expectations and incorporate the patient's goals and preferences and promoting multidisciplinary team collaboration in patient care. Ultimately, policy-level changes are required to improve EOL care for patients who are transfusion-dependent. Many research efforts to improve the care of patients with hematologic malignancies at the end of life are underway, including studies directed toward patients dependent on transfusions.

http://dx.doi.org/10.1182/hematology.2024000560

Voir la revue «Hematology. American Society of Hematology. Education program, 2024»

Autres numéros de la revue «Hematology. American Society of Hematology. Education program»

Consulter en ligne

Suggestions

Du même auteur

Challenges in hospice and end-of-life care in...

Article | RODENBACH, Rachel | Hematology. American Society of Hematology. Education program | n°1 | vol.2024

Despite promising advances leading to improved survival, many patients with hematologic malignancies end up dying from their underlying disease. Their end-of-life (EOL) care experience is often marked by worsening symptoms, late c...

Coaching palliative care conversations : eval...

Article | RODENBACH, Rachel | JOURNAL OF PALLIATIVE MEDICINE | n°2 | vol.23

Background: There is increasing need for nonspecialty physicians to deliver palliative care (PC) services to meet patient needs, but many physicians feel inadequately prepared. Objective: We aimed to improve the PC skills of resid...

Coaching palliative care conversations : eval...

Article indépendant | RODENBACH, Rachel | JOURNAL OF PALLIATIVE MEDICINE | n°2 | vol.23

Background: There is increasing need for nonspecialty physicians to deliver palliative care (PC) services to meet patient needs, but many physicians feel inadequately prepared. Objective: We aimed to improve the PC skills of resid...

De la même série

Challenges in hospice and end-of-life care in...

Article indépendant | RODENBACH, Rachel | Hematology. American Society of Hematology. Education program | n°1 | vol.2024

Despite promising advances leading to improved survival, many patients with hematologic malignancies end up dying from their underlying disease. Their end-of-life (EOL) care experience is often marked by worsening symptoms, late c...

End-of-life care for people with sickle cell ...

Article indépendant | PATEL, Rushil V. | Hematology. American Society of Hematology. Education program | n°1 | vol.2024

End-of-life (EOL) care is a critical part of sickle cell disease (SCD) management. However, barriers to high-quality EOL care remain, including (1) disease-related barriers (prior opioid exposure, risk of vaso-occlusive crises, ch...

Anticoagulation at the end of life : whether,...

Article indépendant | PARKS, Anna L. | Hematology. American Society of Hematology. Education program | n°1 | vol.2024

Nearly 2 out of 3 patients with venous thromboembolism (VTE) and 1 out of 4 patients with atrial fibrillation (AF) will die within the year. Whether, when, and how to manage anticoagulation at the end of life requires many trade-o...

Chargement des enrichissements...